Gene · 57794
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,521 to 1,540 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of HnRNPC as a novel Tau exon 10 splicing factor using RNA antisense purification mass spectrometry. | RNA Biol | 2022 | 34965173 | PubTator, text mining | PubMed |
| Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer. | Mol Ther Nucleic Acids | 2022 | 34938606 | PubTator, text mining | PubMed |
| Compact QEPAS humidity sensor in SF6 buffer gas for high-voltage gas power systems. | Photoacoustics | 2022 | 34934620 | PubTator, text mining | PubMed |
| Role of AUF1 in modulating the proliferation, migration and senescence of skin cells. | Exp Ther Med | 2022 | 34934424 | PubTator, text mining | PubMed |
| Subcellular Transcriptomics and Proteomics: A Comparative Methods Review. | Mol Cell Proteomics | 2022 | 34922010 | PubTator, text mining | PubMed |
| Circular RNAs in stem cells: from basic research to clinical implications. | Biosci Rep | 2022 | 34908111 | PubTator, text mining | PubMed |
RNA-binding proteins and post-transcriptional regulation in lens biology and cataract: Mediating spatiotemporal expression of key factors that control the cell cycle, transcription, cytoskeleton and transparency. | Exp Eye Res | 2022 | 34906599 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Alternative Splicing in Gastric Cancer Identifies Epithelial-Mesenchymal Transition Subtypes Associated with Survival. | Cancer Res | 2022 | 34903603 | PubTator, text mining | PubMed |
| Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells. | RNA Biol | 2022 | 34895045 | PubTator, text mining | PubMed |
| The double-stranded RNA-binding protein, Staufen1, is an IRES-transacting factor regulating HIV-1 cap-independent translation initiation. | Nucleic Acids Res | 2022 | 34893869 | PubTator, text mining | PubMed |
| Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States. | J Natl Cancer Inst | 2022 | 34893865 | PubTator, text mining | PubMed |
| Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers. | J Infect Chemother | 2022 | 34887175 | PubTator, text mining | PubMed |
| Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD. | Acta Neuropathol | 2022 | 34874463 | PubTator, text mining | PubMed |
| Distinct noncoding RNAs and RNA binding proteins associated with high-risk pediatric and adult acute myeloid leukemias detected by regulatory network analysis. | Cancer Rep (Hoboken) | 2022 | 34862757 | PubTator, text mining | PubMed |
| Immunomodulation of COVID-19 severity by helminth co-infection: Implications for COVID-19 vaccine efficacy. | Immun Inflamm Dis | 2022 | 34861106 | PubTator, text mining | PubMed |
| Knowledge-guided artificial intelligence technologies for decoding complex multiomics interactions in cells. | Clin Exp Pediatr | 2022 | 34844399 | PubTator, text mining | PubMed |
| Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune disease. | Mol Immunol | 2022 | 34839165 | PubTator, text mining | PubMed |
| Alexander disease: models, mechanisms, and medicine. | Curr Opin Neurobiol | 2022 | 34826654 | PubTator, text mining | PubMed |
| Drug delivery approaches for HuR-targeted therapy for lung cancer. | Adv Drug Deliv Rev | 2022 | 34822926 | PubTator, text mining | PubMed |
| YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation. | Cell Prolif | 2022 | 34821414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57794/papers?page=77